News

U.S. FDA Approves Zanubrutinib for the Treatment of WM

BREAKING NEWS The IWMF is excited to share that the U.S. Food and Drug Administration (FDA) has approved the use of Zanubrutinib for the treatment of WM. From IWMF Board Chair, Peter DeNardis: “The approval of Brukinsa in Waldenström’s macroglobulinemia, which is the...

Important IWMF Update: 2021 Educational Forum

To the IWMF Community, We want to let you know that after very careful consideration and with input from our WM medical experts, we have made the decision that our 2021 Ed Forum will be a completely virtual event. We are disappointed that we will not be together in...

Participate in LLS COVID-19 Antibody Research Study

The Leukemia & Lymphoma Society (LLS) is undertaking a unique research study focusing on the antibody response among blood cancer patients in the United States. Participating is easy, and the end result will be a large-scale collection of data from vaccinated...

IWMF COVID-19 News Brief – January 2021

IWMF COVID-19 News Brief – January 2021 While the coronavirus (COVID-19) pandemic continues to affect the global community, several vaccines have either been approved or are in trials for helping to head off the ill effects of the virus. At this time, there are 3...

IWMF COVID-19 NEWS BRIEF – DECEMBER 2020

The coronavirus (COVID-19) pandemic has affected the global community, with each country developing safety protocols of different types and durations. We know that the IWMF community has many questions about the vaccine, and we hope this news brief offers helpful...

Special New Year’s Walk for Waldenstrom’s

JOIN US FOR A SPECIAL NEW YEAR’S WALK FOR WALDENSTROM’S With Stacy Kennedy MPH, RD, CSO, LDN Help the IWMF meet its goals while achieving your own! Join your friends in the WM community for a special New Year’s Walk for Waldenstrom’s, and end...

Share This